Clinical and Experimental Neuroimmunology
SJR0.353
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.353 | Q3 | 49.1% | |
| 2024 | — | — | 0.373 | Q3 | 52.7% | |
| 2023 | — | — | 0.213 | Q4 | 37.3% | |
| 2022 | — | — | 0.195 | Q4 | 36.6% | |
| 2021 | — | — | 0.225 | Q4 | 42.7% | |
| 2020 | — | — | 0.297 | Q3 | 50.0% | |
| 2019 | — | — | 0.279 | Q3 | 50.0% | |
| 2018 | — | — | 0.245 | Q3 | 43.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
1759-1961
region
Western Europe
coverage
2010-2026